Kiora Shares Rise On Being Issued U.S. And European Patents

Kiora Shares Rise On Being Issued U.S. And European Patents For Its KIO-100 Family Of Compounds

Shares of Kiora Pharmaceuticals, Inc. (KPRX) are up 13% on Wednesday after the company was issued U.S. and European Patents for local ocular delivery of the KIO-100 family of non-steroidal, anti-inflammatory small molecules.

Related Keywords

, Brian Strem , Kiora Pharmaceuticals Inc , Nasdaq , Kiora Pharmaceuticals , European Patents , Patents ,